Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M. Dreyling; M. Ghielmini; Robert Marcus; G. Salles; U. Vitolo; ESMO Guidelines Working Grp

doi:10.1093/annonc/mdr388

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M. Dreyling, M. Ghielmini, Robert Marcus, G. Salles, U. Vitolo, ESMO Guidelines Working Grp

Research output: Contribution to journal › Article › peer-review

63 Citations (Scopus)

Original language	English
Pages (from-to)	vi59-vi63
Number of pages	5
Journal	Annals of Oncology
Volume	22
Issue number	suppl 6
DOIs	https://doi.org/10.1093/annonc/mdr388
Publication status	Published - Sept 2011

Keywords

STEM-CELL TRANSPLANTATION
INTERNATIONAL PROGNOSTIC INDEX
PROGRESSION-FREE SURVIVAL
NON-HODGKINS-LYMPHOMA
HIGH-DOSE THERAPY
HIGH-RISK
RITUXIMAB
TRIAL
CHEMOTHERAPY
METAANALYSIS

Access to Document

10.1093/annonc/mdr388

Cite this

@article{6dbbd00ab07e46f4841d98efb89ada39,

title = "Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",

keywords = "STEM-CELL TRANSPLANTATION, INTERNATIONAL PROGNOSTIC INDEX, PROGRESSION-FREE SURVIVAL, NON-HODGKINS-LYMPHOMA, HIGH-DOSE THERAPY, HIGH-RISK, RITUXIMAB, TRIAL, CHEMOTHERAPY, METAANALYSIS",

author = "M. Dreyling and M. Ghielmini and Robert Marcus and G. Salles and U. Vitolo and {ESMO Guidelines Working Grp}",

year = "2011",

month = sep,

doi = "10.1093/annonc/mdr388",

language = "English",

volume = "22",

pages = "vi59--vi63",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "suppl 6",

}

TY - JOUR

T1 - Newly diagnosed and relapsed follicular lymphoma

T2 - ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

AU - Dreyling, M.

AU - Ghielmini, M.

AU - Marcus, Robert

AU - Salles, G.

AU - Vitolo, U.

AU - ESMO Guidelines Working Grp

PY - 2011/9

Y1 - 2011/9

KW - STEM-CELL TRANSPLANTATION

KW - INTERNATIONAL PROGNOSTIC INDEX

KW - PROGRESSION-FREE SURVIVAL

KW - NON-HODGKINS-LYMPHOMA

KW - HIGH-DOSE THERAPY

KW - HIGH-RISK

KW - RITUXIMAB

KW - TRIAL

KW - CHEMOTHERAPY

KW - METAANALYSIS

U2 - 10.1093/annonc/mdr388

DO - 10.1093/annonc/mdr388

M3 - Article

SN - 0923-7534

VL - 22

SP - vi59-vi63

JO - Annals of Oncology

JF - Annals of Oncology

IS - suppl 6

ER -